Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Actas Esp Psiquiatr ; 47(3): 88-96, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-31233207

RESUMEN

OBJECTIVES: To compare alcohol and other drugs abuse, state impulsivity, craving and the relationship between craving and impulsivity in alcohol-dependent patients with or without dual disorder attending to an alcohol treatment center in Cadiz town. METHOD: An observational, descriptive and transversal study performed on 112 alcohol dependent patient sample who were seeking treatment in ARCA outpatient treatment center in Cadiz. The sample was divided in two groups, according to present dual diagnosis or not. The sample was assessed with an AdHoc sociodemographic and clinical questionnaire and specific scales and interviews that included: 5.0 Mini International Neuropsychiatric Interview results (MINI), State Impulsivity Scale (SIS), and Multidimensional Alcohol Craving Scale (MACS). RESULTS: The prevalence of dual diagnosis was 50%, being the most prevalent disorders: Current and recurrent Major Depressive Episode Mood Disorder, Current Dysthymic Mood Disorder, Panic Disorder and Anxiety Disorder. 52,7% of the total sample had a positive result on the State Impulsivity Scale. No statistically significant results were found on the Craving Scale (neither in the score or in the sub-sections). A relationship between craving and impulsivity were found for all groups and researched items. CONCLUSIONS: As a relationship between craving and impulsivity was observed, these aspects should be considered as main factors for the treatment and evolution of alcohol- dependent patients.


Asunto(s)
Trastornos Relacionados con Alcohol/epidemiología , Ansia/efectos de los fármacos , Trastorno Depresivo Mayor/epidemiología , Conducta Impulsiva/efectos de los fármacos , Pacientes Ambulatorios/estadística & datos numéricos , Estudios Transversales , Diagnóstico Dual (Psiquiatría) , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Escalas de Valoración Psiquiátrica , España/epidemiología
2.
Rev Colomb Psiquiatr (Engl Ed) ; 50(1): 43-46, 2021.
Artículo en Inglés, Español | MEDLINE | ID: mdl-33648696

RESUMEN

Ayahuasca is a psychotropic infusion prepared by boiling the bark of Amazonian plants and has many psychopharmacological effects not fully understood. Some of those effects are used as treatment for different diseases. However, the side effects of ayahuasca, including ayahuasca-induced psychosis, are an important issue. Here we report the case of a patient who had a psychotic episode after taking ayahuasca and who was successfully treated with antipsychotic medication. Given the current spread of ayahuasca consumption in developed societies, the present case highlights the need for better understanding and regulation of the social-legal condition of ayahuasca and the need for further research. Additionally, psycho-education seems advisable in order to create awareness of the potential risks of the use of ayahuasca.

3.
Psychiatry Res ; 262: 440-445, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-28951146

RESUMEN

Risks factors for suicide are multiple and highly prevalent in addicted patients (previous suicide attempts, substance abuse, impulsivity, history of sexual abuse and other factors). The aim of this study is to identify and to compare the clinical and socio-demographic profile of SUD outpatients with lifetime suicidal behavior (previous suicidal ideation and/or suicide attempts) and to analyze the factors related to it. A retrospective cohort study of 696 addicted patients, according to DSM-IV-TR criteria (APA, 2000) were collected from the Addiction Unit of Vall d'Hebron University Hospital. Lifetime suicidal ideation in addicted patients is associated with presence of: borderline personality disorder (BPD), depressive disorders, sexual abuse, polydrug abuse, attention-deficit hyperactivity disorder, and motor impulsivity. The factors associated with suicide attempts were: borderline personality disorder, lifetime abuse (whether emotional, physical or sexual), co-occurrent psychotic disorders, polydrug abuse, anxiety disorders and depressive symptoms. We conclude that previous suicidal ideation and lifetime suicide attempts should be considered in the clinical care of addicted patients. Factors related to both suicidal behaviors share similarities and differences according to our findings and need to be deeply explored in the future.


Asunto(s)
Trastorno de Personalidad Limítrofe/epidemiología , Trastorno Depresivo/epidemiología , Conducta Impulsiva , Trastornos Relacionados con Sustancias/epidemiología , Ideación Suicida , Intento de Suicidio/estadística & datos numéricos , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pacientes Ambulatorios/estadística & datos numéricos , Estudios Retrospectivos , España/epidemiología
4.
Med Clin (Barc) ; 150(2): 49-55, 2018 01 23.
Artículo en Inglés, Español | MEDLINE | ID: mdl-28736069

RESUMEN

BACKGROUND AND OBJECTIVE: Dual diagnosis is the coexistence of an addictive disorder and another mental disorder. The objective is to estimate cravings and self-reported quality of life in a sample of patients with alcoholic dependence, with or without dual pathology, who attend an outpatient treatment centre. PATIENTS AND METHOD: A cross-sectional study of 112 patients (56 dual and 56 non-dual), diagnosed with alcohol dependence according to DSM-IV-TR. The presence of cravings is determined by the Multidimensional Alcohol Craving Scale and quality of life through the SF-36 Health Questionnaire. RESULTS: There are no statistically significant differences in cravings in either subgroup; the latter tend to refer to lower alcohol cravings than non-dual patients. The dual patients have a worse quality of life in all categories evaluated, highlighting a worse quality of life in the categories: social function, emotional role, vitality and general health. Females present a lower quality of life emphasising those of social function and emotional role. No differences were detected in relation to cravings between the 2 groups. CONCLUSIONS: In order to perform a correct clinical and therapeutic approach for patients with alcohol dependence, we should consider focusing on the evaluation of cravings and quality of life. In order to perform a correct clinical and therapeutic approach for patients with alcohol dependence, it is necessary to consider cravings and quality of life, since these parameters are important for the evaluation of patients with alcohol dependence.


Asunto(s)
Alcoholismo/psicología , Ansia , Diagnóstico Dual (Psiquiatría)/psicología , Calidad de Vida , Adulto , Anciano , Anciano de 80 o más Años , Alcoholismo/terapia , Atención Ambulatoria , Estudios de Casos y Controles , Estudios Transversales , Femenino , Indicadores de Salud , Humanos , Masculino , Persona de Mediana Edad , Calidad de Vida/psicología , Autoinforme
5.
Psychiatry Res ; 261: 361-366, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29353762

RESUMEN

There has been little research about deleterious effects, including cognitive impairment, related to hazardous long-term alcohol use in old adults. This study aims to assess cognitive decline in old patients with alcohol use disorder and changes in cognitive state at 6 months follow-up, achieving or not abstinence. A six-month follow-up study was conducted in an outpatient center in Barcelona on a sample of old adults (≥65 years old) who had hazardous alcohol use. The sample was compared with healthy volunteers adjusted for age, sex and years of education. A neuropsychological protocol was performed at baseline and after 6 months follow-up covering four cognitive domains: attention, visuospatial abilities, memory and executive functions. Several domains were significant impaired at baseline: visual immediate and delayed recall, working memory, immediate verbal learning, total words learned, set switching and sustained attention. At 6 months reassessment, alcohol abstinence was achieved in 93.5% of patients and it was detected a trend towards improvement in direct mean scores of all cognitive areas, although it was not significant. The current study points out a cognitive impairment in many areas secondary to alcohol long-term hazardous use in old adults. A trend towards cognitive improvement after recovery was detected in most patients.


Asunto(s)
Alcoholismo/psicología , Disfunción Cognitiva/etiología , Anciano , Abstinencia de Alcohol/psicología , Atención , Función Ejecutiva , Femenino , Estudios de Seguimiento , Humanos , Masculino , Memoria a Corto Plazo , Pacientes Ambulatorios/psicología , España , Factores de Tiempo , Aprendizaje Verbal
6.
Clin Neuropharmacol ; 40(6): 281-285, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29045249

RESUMEN

OBJECTIVES: Episodes of agitation are frequent in intoxicated patients who have a substance use disorder, a psychiatric disorder or both (dual diagnosis). For managing the agitation, it is necessary to act promptly in a safe environment and addressing any underlying etiology. Inhaled loxapine improves symptoms of agitation in adults with psychiatric disorders (eg, schizophrenia) within 10 minutes of administration. Recently, some reports have documented the usefulness of loxapine in dual diagnoses patients with agitation. However, the efficacy of loxapine in intoxicated patients has not been deeply addressed. METHODS: This report describes a case series of 12 patients (with addiction or dual disorder) who received inhaled loxapine for symptoms of psychomotor agitation during intoxication with different substances (eg, alcohol, cannabis, or cocaine) at 1 center in Spain. RESULTS: Data from 12 patients were reviewed, 5 patients were attended at the emergency room, 4 at the addiction and dual diagnosis unit, and 3 were treated during hospitalization for detoxification. All patients were under effects of substances. They had substance use disorder (including cannabis, cocaine, alcohol, hypnotics, and hallucinogens), and almost all (90%) presented 1 or more psychiatric disorders. One dose of inhaled loxapine was effective in 9 patients (75%), and in 3 patients, a second dose was required. Only mild dizziness was reported in 1 patient after the second dose. CONCLUSIONS: The acute agitation was effectively and quickly managed with inhaled loxapine in all intoxicated patients and enabled the appropriate clinical evaluation of the agitated state and the patient's management.


Asunto(s)
Antipsicóticos/administración & dosificación , Servicios Médicos de Urgencia/métodos , Loxapina/administración & dosificación , Trastornos Mentales/tratamiento farmacológico , Agitación Psicomotora/tratamiento farmacológico , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Administración por Inhalación , Adulto , Intoxicación Alcohólica/complicaciones , Intoxicación Alcohólica/diagnóstico , Intoxicación Alcohólica/tratamiento farmacológico , Femenino , Humanos , Masculino , Trastornos Mentales/complicaciones , Trastornos Mentales/diagnóstico , Agitación Psicomotora/complicaciones , Agitación Psicomotora/diagnóstico , Trastornos Relacionados con Sustancias/complicaciones , Trastornos Relacionados con Sustancias/diagnóstico
7.
Rev. colomb. psiquiatr ; 50(1): 43-46, Jan.-Mar. 2021.
Artículo en Inglés | LILACS, COLNAL - Colombia-Nacional | ID: biblio-1251632

RESUMEN

A B S T R A C T Ayahuasca is a psychotropic infusion prepared by boiling the bark of Amazonian plants and has many psychopharmacological effects not fully understood. Some of those effects are used as treatment for different diseases. However, the side effects of ayahuasca, including ayahuasca-induced psychosis, are an important issue. Here we report the case of a patient who had a psychotic episode after taking ayahuasca and who was successfully treated with antipsychotic medication. Given the current spread of ayahuasca consumption in developed societies, the present case highlights the need for better understanding and regulation of the social-legal condition of ayahuasca and the need for further research. Additionally, psycho-education seems advisable in order to create awareness of the potential risks of the use of ayahuasca.


RESUMEN La ayahuasca es una bebida psicotrópica preparada a través de la cocción de plantas de la cuenca amazónica que tiene muchos efectos psicofarmacológicos no del todo estudiados. Algunos de esos efectos son usados como tratamiento de diversas patologías. Sin embargo, existen efectos secundarios de la ayahuasca que deben ser tenidos en cuenta, entre ellos psicosis inducida por ayahuasca. Reportamos un caso de un paciente que, tras autoadministración de ayahuasca, presentó un episodio psicótico y que fue satisfactoriamente tratado con antipsicóticos. Dada el uso cada vez más frecuente de ayahuasca en las sociedades desarrolladas, el caso actual resalta las necesidades de entender, regular e investigar el uso de la ayahuasca. Además, crear conciencia de los potenciales riesgos del uso de ayahuasca a través de la psicoeducación debería ser implementado.


Asunto(s)
Humanos , Masculino , Adulto , Plantas , Trastornos Psicóticos , Autoadministración , Control Social Formal , Concienciación , Terapéutica , Antipsicóticos , Banisteriopsis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA